applying for approval
Scope
Date
~
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Electronics
Galaxy Watch's alarm of abnormal heartbeat gets approval in S.Korea
Samsung Electronics Co.'s new feature on the Galaxy Watch, which detects heartbeats and alerts the possibility of risks such as arrhythmia, can now ...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s top pharmaceutical distributor buys 25% of No. 2 Baekje Pharma
South Korea’s top pharmaceutical distributor Geo-young Co. has acquired 25% of market No. 2 Baekje Pharmaceutical.Geo-young on Tuesday said th...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Energy
Hanwha Q Cells sweeps global solar energy industry awards
Hanwha Q Cells Co.'s winning of major global solar energy industry prizes is expected to help the unit of South Korean Hanwha Solutions Corp. cement...
Jun 08, 2023 (Gmt+09:00)
-
Airlines
Korean Air says it can conclude Asiana takeover via big concessions
The head of Korean Air Lines Co. has expressed confidence over the airliner's proposed acquisition of Asiana Airlines, saying, "We will make it happ...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins contract to build blood products plant in Indonesia
GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...
Jun 02, 2023 (Gmt+09:00)
-
Artificial intelligence
South Korea’s Hyundai Elevator applies AI to boost customer convenience
"Miri is a leading example of digital transformation in the elevator sector that raises a notch service speed and customer convenience. Let’s ...
Jun 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets approval to sell biosimilar in Europe
South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea to apply private advanced tech to military weapons in 5 years
South Korea has approved a fast-track system that slashes complex administrative procedures for application of private technology to the military&rs...
May 11, 2023 (Gmt+09:00)
-
Chemical Industry
CJ CheilJedang gets FDA approval for biodegradable packaging material
South Korea's largest food and bio company CJ CheilJedang Corp. announced on Thursday that its biodegradable material polyhydroxyalkanoate (PHA) has...
May 04, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets marketing approval for epilepsy drug in Israel
South Korea’s SK Biopharmaceuticals said on Wednesday that the Israeli Ministry of Health has approved the company's new drug application (NDA...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Korea clears way for Hanwha's $1.45 bn takeover of DSME
South Korea’s Fair Trade Commission (FTC) on Thursday gave its nod for Hanwha Group’s 2-trillion-won ($1.45 billion) takeover of Daewoo ...
Apr 27, 2023 (Gmt+09:00)
-
The KED View
In South Korea, innovation is subject to regulatory approval
In a country like South Korea with few natural resources to run its economy, innovations or brilliant business ideas are crucial to its survival.It ...
Apr 26, 2023 (Gmt+09:00)
-
Bio & Pharma
CG Bio establishes US corporation to develop tissue products
South Korean bio-regenerative medical firm CG Bio has launched a new US corporation CG MedTech, to focus on the development and marketing of tissue ...
Apr 25, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
S.Korean firms applies for record-high 76,592 patents abroad in 2022
The Korean Intellectual Property Office (KIPO) on Thursday said the number of patents filed overseas by domestic companies last year set a record-hi...
Apr 21, 2023 (Gmt+09:00)
-
Food & Beverage
Kolmar BNH gets approval for health functional food ingredient in US
Kolmar BNH Co. has received approval from the US Food and Drug Administration (FDA) for a domestically developed health functional food ingredient.K...
Apr 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Welt gets second digital therapeutic device approval in S. Korea
South Korea's Ministry of Food and Drug Safety announced on Wednesday that it has approved the cognitive therapy software "WELT-I" developed by We...
Apr 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer
South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
-
Corporate investment
S.Korean corporate investment in Vietnam plunges 70% in first quarter
South Korean corporate investment in Vietnam, which has led the economic development of the Southeast Asian nation, has plunged this year due to fac...
Apr 11, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hyundai Autoever, Avikus jointly develop self-sailing ship solution
South Korea’s Hyundai Autoever and Avicus, the self-navigation vessel affiliate of HD Hyundai, on Tuesday said they signed a development contr...
Apr 05, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Foreigners can enter S.Korean casino without physical passport
Visitors to South Korea will be able to enjoy tax-free shopping and casino experiences with ease, thanks to the mobile passport identity verificatio...
Apr 04, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha's takeover of DSME likely to get conditional approval
South Korea's Fair Trade Commission (FTC) on Monday said it is discussing corrective measures with Hanwha Group over fears that the conglomerate's a...
Apr 04, 2023 (Gmt+09:00)
-
Electronics
Doosan, Ionic Materials collaborate in liquid crystal polymer
Doosan Corp., the holding company of South Korea's Doosan Group, said on Monday that it has entered a joint development agreement (JDA) with US-base...
Apr 03, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand